The observed reduction in STAT1 expression suggests a feedback regulatory mechanism of pSTAT1 on its own promoter, already documented,35 as well as an EGFR/HER2-dependent regulation as previously shown in glioblastoma and breast cancer cell lines.48 This evidence concerns the gene ERBB2 and breast cancer.